What is Scipher Medicine's Platform?

Scipher's platform identifies which drug will work based on the patient's fundamental disease biology, and not based on symptoms, disease classification, or medical bias.

Powered by AI and Network Science.

Deciphering the complexity of disease biology by analyzing large patient molecular data sets through the unique lens of the human interactome and AI.

A Decade of Research

Built upon over a decade of experimental research, the platform’s backbone is the network map of human biology explaining how proteins expressed from the human genome interact to cause specific disease phenotypes, providing the wiring diagram needed to interpret dynamic individual patient molecular data to reveal actual disease biology.

Not a Model

It is not a model, but a disease representation rooted in experimental human biology.

Precision Medicine

Identifies a patient’s unique disease signature, predicts drug response to approved drugs and identifies novel drug targets for patients not responding to existing therapies.

Keeps Learning

As Spectra interprets more patient molecular datasets, the platform learns to provide further insight into disease biology make-up and patient stratification.

About Scipher

Scipher Medicine, a precision immunology company matching each patient with their most effective therapy, believes that patients deserve simple answers to treatment options based on scientific data. Using Spectra™, our proprietary network medicine platform, we commercialize tests revealing a person’s unique molecular disease signature and match it to the most effective therapy, ensuring optimal treatment from day one. The patient molecular data generated from our tests further supports the discovery and development of novel and more effective therapeutics. We partner with leading payers, health care providers, and pharmaceutical companies to bring solutions to patients with autoimmune diseases. Visit sciphermedicine.com and follow Scipher Medicine on Twitter, Facebook, and LinkedIn.

Contacts

Media Relations 

Corporate Communications 

pr@scipher.com  

Investor Relations 

ir@scipher.com